Congress Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-116,110
Closed -$1.73M 1205
2025
Q1
$1.73M Sell
116,110
-5,741
-5% -$88.3K 0.02% 525
2024
Q4
$1.82M Sell
121,851
-13,308
-10% -$217K 0.03% 424
2024
Q3
$2.59M Buy
+135,159
New +$2.8M 0.03% 385

Other funds holding OGN

Congress Wealth Management's OGN Position: Q2 2025 in Review

Congress Wealth Management sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 116,110 shares — an estimated $1.73M sold.

Congress Wealth Management first reported a position in OGN in Q3 2024 and held it in 3 quarters. The position peaked at $2.59M in Q3 2024. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Congress Wealth Management reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Congress Wealth Management sold 116,110 Organon & Co shares in Q2 2025, an estimated $1.73M.
  • Congress Wealth Management first reported a position in Organon & Co in Q3 2024 and held it in 3 quarters.
  • Congress Wealth Management's Organon & Co position peaked at $2.59M in Q3 2024.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Congress Wealth Management's 13F filing for Q2 2025, filed 13 Aug 2025.